Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S. Bakris GL, et al. Among authors: vicknair n. Kidney Int. 1996 Nov;50(5):1641-50. doi: 10.1038/ki.1996.480. Kidney Int. 1996. PMID: 8914031 Free article. Clinical Trial.
Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.
Bakris GL, Mangrum A, Copley JB, Vicknair N, Sadler R. Bakris GL, et al. Among authors: vicknair n. Hypertension. 1997 Mar;29(3):744-50. doi: 10.1161/01.hyp.29.3.744. Hypertension. 1997. PMID: 9052890 Clinical Trial.
ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects.
Bakris GL, Slataper R, Vicknair N, Sadler R. Bakris GL, et al. Among authors: vicknair n. J Diabetes Complications. 1994 Jan-Mar;8(1):2-6. doi: 10.1016/1056-8727(94)90003-5. J Diabetes Complications. 1994. PMID: 8167383 Clinical Trial.
Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
Slataper R, Vicknair N, Sadler R, Bakris GL. Slataper R, et al. Among authors: vicknair n. Arch Intern Med. 1993 Apr 26;153(8):973-80. Arch Intern Med. 1993. PMID: 8386921 Clinical Trial.
Feedback